Unique cannabis vaporizer under evaluation in Israel
Filed with ASX · · 2 pages · English
Nexalis Therapeutics Limited on 6ix
Earlier from Nexalis Therapeutics
- Amended Appendix 4C - Cash balance at 31/3 $3.904M
- Update on development of unique cannabis vaporizer
- New Patient Self-Management System Launched
- Lifespot Health restructures its Business and Board
- Lifespot Signs Global Agreement With Beurer
Later from Nexalis Therapeutics
- B.Braun to launch Omnitest 5 BT with Body-Tel
- LSH in discussions to finance integrated cannabis producers
- Update on Unique Cannabis Vaporiser launch and Bodytel
- Lifespot Strengthens Go-To-Market Cannabis Strategy
- LSH Acquires Seng Vital for Cannabis Opportunities
Follow Nexalis Therapeutics into a list and get an email when it puts out news.
Follow Nexalis Therapeutics